News
08-01-2025
ESMP pre-launch for MAHs and available training materials
As of 28 November 2024, the
European Shortages Monitoring Platform (ESMP)
is officially live for routine shortage reporting by marketing authorisation holders (MAHs).
Marketing authorisation holders (MAHs) can now submit data to routinely report shortages of centrally authorised medicines (CAPs) to EMA. This marks the start of a transition period that will end on 2 February 2025, when the use of the platform becomes mandatory for CAP shortage reporting to EMA. National reporting requirements remain applicable. The ESMP will enable information exchange for prevention, identification and management of shortages to ensure medicines are available for patients in the EU and EEA.
The full first version of the ESMP will be released by 2 February 2025 and will expand the platform's functionalities to include supply, demand, and availability reporting during crises and MSSG-led preparedness exercises by MAHs and NCAs.
Further information, including training materials, user guidance, and
ESMP webinar
and
ESMP training
event recordings, are available on EMA's website to support stakeholders. For more details, visit the
ESMP webpage
and the
press release on EMA's website.
|